Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$56.61 - $80.46 $151,488 - $215,310
-2,676 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$86.23 - $125.19 $230,751 - $335,008
2,676 New
2,676 $249,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $192,090 - $252,897
-3,453 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $49,291 - $62,984
-947 Reduced 21.52%
3,453 $240,000
Q2 2018

Aug 22, 2018

SELL
$48.33 - $55.64 $1,933 - $2,225
-40 Reduced 0.9%
4,400 $222,000
Q1 2018

Jun 25, 2018

BUY
$44.44 - $54.39 $197,313 - $241,491
4,440 New
4,440 $234,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $499M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.